Skip to main content
Clinical Trials/JPRN-UMIN000018970
JPRN-UMIN000018970
Completed
未知

An observational study to investigate patient-reported satisfaction with apixaban when switched from warfarin in Japanese NVAF patients (AGAIN study) - Patient-reported satisfaction in Japanese NVAF patients (AGAIN Study)

Pfizer Japan Inc.0 sites865 target enrollmentSeptember 11, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
on-valvular atrial fibrillation
Sponsor
Pfizer Japan Inc.
Enrollment
865
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 11, 2015
End Date
December 25, 2016
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients whose warfarin is switched to apixaban at the timing of invasive procedures other than catheter ablation for treatment of AF. 2\.Patients with a history of hypersensitivity to the active substance (apixaban) or to any of the excipients of this drug 3\.Patients with clinically significant active bleeding. (judged by a physician in charge of the patients) 4\.Patients with hepatic disease associated with coagulopathy and clinically relevant bleeding risk. (judged by a physician in charge of the patients) 5\.Patients with renal failure (creatinine clearance \<15 mL/min) (No clinical experience) 6\.Patients who are not able to answer to the questionnaires.

Outcomes

Primary Outcomes

Not specified

Similar Trials